Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PTCT — Ptc Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,776,099
+$4,709,922 QoQ
Shares Held
83,071
+173.9% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PTCT ranks #43 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PTCT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,776,099 83,071
2026-03-31 $2,066,177 30,327
2025-12-31 $6,602,518 86,921
2025-09-30 $3,157,055 51,443
2025-06-30 $2,145,882 43,937
2025-03-31 $2,005,529 39,355
2024-12-31 $1,722,000 38,148
2024-09-30 $988,677 26,649
2024-06-30 $942,994 30,837
2024-03-31 $803,028 27,605
2023-12-31 $700,354 25,412
2023-09-30 $1,194,407 53,298
2023-06-30 $2,576,117 63,342
2023-03-31 $1,933,045 39,906
2022-12-31 $43,627 1,143
2022-09-30 $151,099 3,010
2022-06-30 $153,228 3,825
2022-03-31 $1,420,054 38,061
2021-12-31 $2,413,895 60,605
2021-09-30 $2,143,703 57,611
2021-06-30 $1,933,512 45,742
2021-03-31 $3,228,369 68,181
2020-12-31 $5,172,902 84,760
2020-09-30 $3,091,436 66,127
2020-06-30 $8,557,705 168,658
2020-03-31 $5,482,923 122,908